EGP

N-[2-(1H-indol-3-yl)ethyl]-N'-{3-[(4-methylpiperazin-1-yl)methyl]-1-[2-(morpholin-4-yl)-2-oxoethyl]-1H-indol-6-yl}thiourea

Created:	2018-01-10
Last modified:	2019-01-16

Find Related PDB Entry
1 entries where EGP is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	80
Chiral Atom Count	0
Bond Count	85
Aromatic Bond Count	20

2D diagram of EGP

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[2-(1H-indol-3-yl)ethyl]-N'-{3-[(4-methylpiperazin-1-yl)methyl]-1-[2-(morpholin-4-yl)-2-oxoethyl]-1H-indol-6-yl}thiourea
Systematic Name (OpenEye OEToolkits)	1-[2-(1~{H}-indol-3-yl)ethyl]-3-[3-[(4-methylpiperazin-1-yl)methyl]-1-(2-morpholin-4-yl-2-oxidanylidene-ethyl)indol-6-yl]thiourea
Formula	C₃₁ H₃₉ N₇ O₂ S
Molecular Weight	573.752
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	n2(cc(CN1CCN(C)CC1)c3ccc(cc23)NC(NCCc4cnc5ccccc45)=S)CC(=O)N6CCOCC6
SMILES	CACTVS	3.385	CN1CCN(CC1)Cc2cn(CC(=O)N3CCOCC3)c4cc(NC(=S)NCCc5c[nH]c6ccccc56)ccc24
SMILES	OpenEye OEToolkits	2.0.6	CN1CCN(CC1)Cc2cn(c3c2ccc(c3)NC(=S)NCCc4c[nH]c5c4cccc5)CC(=O)N6CCOCC6
Canonical SMILES	CACTVS	3.385	CN1CCN(CC1)Cc2cn(CC(=O)N3CCOCC3)c4cc(NC(=S)NCCc5c[nH]c6ccccc56)ccc24
Canonical SMILES	OpenEye OEToolkits	2.0.6	CN1CCN(CC1)Cc2cn(c3c2ccc(c3)NC(=S)NCCc4c[nH]c5c4cccc5)CC(=O)N6CCOCC6
InChI	InChI	1.03	InChI=1S/C31H39N7O2S/c1-35-10-12-36(13-11-35)20-24-21-38(22-30(39)37-14-16-40-17-15-37)29-18-25(6-7-27(24)29)34-31(41)32-9-8-23-19-33-28-5-3-2-4-26(23)28/h2-7,18-19,21,33H,8-17,20,22H2,1H3,(H2,32,34,41)
InChIKey	InChI	1.03	KSDJEFBPBCSCLA-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	135747590
ChEMBL	CHEMBL4163317

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.